Merus NV MRUS - Options Chain | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Merus NV (MRUS)
Merus NV (MRUS) Options

Merus NV (MRUS)

46.58

-3.08

(-6.20%)

Closed November 16 3:00PM

Delayed by 15 minutes

46.58

0.01

(0.02%)

After Hours: 6:33PM

Delayed by 15 minutes

MRUS Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
12.50	32.00	36.50	0.00	34.25	0.00	0.00 %	0	0	-
15.00	29.50	34.00	0.00	31.75	0.00	0.00 %	0	0	-
17.50	27.10	31.50	0.00	29.30	0.00	0.00 %	0	0	-
20.00	24.50	29.00	0.00	26.75	0.00	0.00 %	0	0	-
22.50	22.20	26.50	0.00	24.35	0.00	0.00 %	0	0	-
25.00	20.00	24.00	0.00	22.00	0.00	0.00 %	0	0	-
30.00	15.00	19.00	17.90	17.00	0.00	0.00 %	1	0	11/15/2024
35.00	10.00	14.50	16.10	12.25	0.00	0.00 %	0	52	-
40.00	5.60	10.00	11.00	7.80	0.00	0.00 %	0	2	-
45.00	2.30	6.50	10.00	4.40	0.00	0.00 %	0	4	-
50.00	0.55	4.20	6.30	2.375	0.00	0.00 %	0	160	-
55.00	0.75	2.40	3.64	1.575	0.00	0.00 %	0	1,067	-
60.00	1.00	1.85	1.00	1.425	-0.20	-16.67 %	1	13	11/15/2024
65.00	0.10	4.90	1.05	2.50	0.00	0.00 %	0	541	-
70.00	0.05	4.90	0.51	2.475	0.00	0.00 %	0	4	-
75.00	1.05	4.90	1.05	2.975	0.00	0.00 %	0	15	-
80.00	0.05	4.90	0.90	2.475	0.00	0.00 %	0	2	-
85.00	0.05	5.00	1.15	2.525	0.00	0.00 %	0	2	-

Empower your portfolio: Real-time discussions and actionable trading ideas.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
12.50	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-
15.00	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-
17.50	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-
20.00	0.05	4.90	0.00	2.475	0.00	0.00 %	0	0	-
22.50	0.05	4.90	0.00	2.475	0.00	0.00 %	0	0	-
25.00	0.10	4.90	0.10	2.50	0.00	0.00 %	0	30	-
30.00	0.15	4.90	0.80	2.525	0.00	0.00 %	0	713	-
35.00	0.10	3.30	0.59	1.70	0.00	0.00 %	0	1,378	-
40.00	0.20	2.80	0.60	1.50	0.00	0.00 %	0	232	-
45.00	0.80	4.60	1.20	2.70	0.00	0.00 %	0	1,010	-
50.00	3.90	7.40	3.60	5.65	0.00	0.00 %	0	460	-
55.00	7.10	11.50	3.70	9.30	0.00	0.00 %	0	735	-
60.00	11.60	15.40	0.00	13.50	0.00	0.00 %	0	0	-
65.00	16.70	20.60	0.00	18.65	0.00	0.00 %	0	0	-
70.00	21.50	25.50	0.00	23.50	0.00	0.00 %	0	0	-
75.00	26.50	30.70	0.00	28.60	0.00	0.00 %	0	0	-
80.00	31.50	35.50	0.00	33.50	0.00	0.00 %	0	0	-
85.00	36.50	41.00	0.00	38.75	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.17B
CYCNCyclerion Therapeutics Inc	US$ 2.5306 (42.97%)	11.99M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	165.69M
PULMPulmatrix Inc	US$ 6.5586 (39.54%)	5.37M
ZTEKZentek Ltd	US$ 1.2574 (29.96%)	309.67k
TFFPTFF Pharmaceuticals Inc	US$ 0.376101 (-76.49%)	9.35M
EYENEyenovia Inc	US$ 0.10185 (-70.05%)	52.8M
CTXRCitius Pharmaceuticals Inc	US$ 0.1974 (-39.89%)	11.26M
VVPRVivoPower International PLC	US$ 0.8151 (-39.62%)	2.34M
IPWiPower Inc	US$ 0.7302 (-39.15%)	1.15M
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.17B
ELABElevai Labs Inc	US$ 0.0211 (-19.47%)	380.03M
NVDANVIDIA Corporation	US$ 141.98 (-3.26%)	253.02M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	165.69M
STISolidion Technology Inc	US$ 0.44 (25.71%)	140.02M

Monksdream

Monksdream 2 months ago

MRUS range bound

Phosphene

Phosphene 4 years ago

Merus and myTomorrows Announce Expansion of Collaboration for Screening and eNRGy Clinical Trial Awareness for Cancer Patients with Neuregulin 1 Fusion Tumors

https://www.globenewswire.com/news-release/2020/10/12/2107078/0/en/Merus-and-myTomorrows-Announce-Expansion-of-Collaboration-for-Screening-and-eNRGy-Clinical-Trial-Awareness-for-Cancer-Patients-with-Neuregulin-1-Fusion-Tumors.html

Phosphene

Phosphene 4 years ago

The Baker Brothers have 7% ownership.

https://whalewisdom.com/filer/baker-bros-advisors-llc#tabholdings_tab_link

Phosphene

Phosphene 4 years ago

Board Member: Victor Sandor

https://ir.merus.nl/board-member/victor-sandor

https://www.businesswire.com/news/home/20200824005127/en/Prelude-Therapeutics-Announces-Closing-50M-Series-Financing

Phosphene

Phosphene 4 years ago

Second Quarter 2020 Results:

https://www.globenewswire.com/news-release/2020/08/06/2074649/0/en/Merus-Announces-Financial-Results-for-the-Second-Quarter-and-Provides-Business-Update.html

Phosphene

Phosphene 4 years ago

https://merus.nl/

Phosphene

Phosphene 4 years ago

European cancer biotech Merus nabs Sanofi I-O chief Andrew Joe

https://www.fiercebiotech.com/biotech/european-cancer-biotech-merus-nabs-sanofi-i-o-chief-andrew-joe

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions